Talk to Sam

+1 917 267 7886

data types

Granulocyte Market and Forecasts, May 2013

You might be interested in: blood supply, stem cell, biosimilar, more »


 
1-10 of about 200 reports for Granulocyte
Biosimilar in India : Innovation and Technology Trends (biosimilar, monoclonal antibody)

Biosimilar in India : Innovation and Technology Trends (biosimilar, monoclonal antibody)

  • Industry report
  • March 2013
  • 32 pages

... Generation products New chemical entities biosimilar business in india biosimilars manufactured in india Erythropoietin granulocyte colony stimulating factor Pegylated ...

The Chinese Protein Industry (protein, recombinant protein)

The Chinese Protein Industry (protein, recombinant protein)

  • Industry report
  • July 2011
  • 14 pages
  • by Research Paper

... The expression of another valuable human colony stimulating factor (csf), human granulocyte-macrophage colony stimulating factor (hgm- csf), widely used as an adjuvant in clinical treatment of neutropenia ...

Biopharmaceutical Sector Brief

Biopharmaceutical Sector Brief

  • Industry report
  • July 2012
  • 16 pages

... Stimulating agent fda: us food and drug administration ffdca: federal food drug and cosmetic act g-csf: granulocyte-colony stimulating factor gcp: good clinical practice gh: growth hormone ghd: growth ...

U.S. Generic Drug Industry : Innovation and Technology Trends

U.S. Generic Drug Industry : Innovation and Technology Trends

  • Industry report
  • July 2012
  • 24 pages

... The way in the biosimilars market with xx approved biosimilars belonging to the erythropoietin (epo) and granulocyte colony stimulating factors (g-csf) and human growth hormones (hgh) groups ...

U.S. G-csf Sector Brief

U.S. G-csf Sector Brief

  • Industry report
  • July 2011
  • 10 pages

... S mobilization response to granulocyte-colony stimulating factor (g-csf) and subsequent cd34h11001 apheresis yields may exert a significant effect on transplant outcomes and donation experiences.4 A small ...

Biological Therapy Sector in Germany

Biological Therapy Sector in Germany

  • Industry report
  • June 2011
  • 12 pages

... Analysis of variance and the bonferroni multiple comparison test were applied for statistical analysis. *P , .05; **P , .01. Abbreviations: gm-csf, granulocyte-macrophage colony-stimulating factor; ifn ...

Biological Therapy Market in Germany

Biological Therapy Market in Germany

  • Industry report
  • September 2011
  • 12 pages

... And the bonferroni multiple comparison test were applied for statistical analysis. *P , .05; **P , .01; ***P , .001. Abbreviations: gm-csf, granulocyte- macrophage colony-stimulating factor; ifn-c, interferon c; il-2 ...

Biological Therapy Business Analysis

Biological Therapy Business Analysis

  • Industry report
  • January 2012
  • 61 pages

... A moderate yield of wbc S, which is consistent with other leading brands, but is the only system that reduces the inflammatory granulocytes in the final product. Best of all Pure prp is naturally ...

Biological Therapy Sector  in Japan and The United States

Biological Therapy Sector in Japan and The United States

  • Industry report
  • July 2011
  • 9 pages

... Was measured with an autohemolytic counter (celltac; nihon koden, tokyo, japan). The phagocyte activity was measured as described by suzuki et al. (2009). The granulocyte/lymphocyte ratio was calculated from ...

U.S. Biological Therapy Industry Analysis

U.S. Biological Therapy Industry Analysis

  • Industry report
  • October 2011
  • 74 pages
  • by Research Paper

... Csf is a cytokine that functions as a white blood cell growth factor. Stem cells produce granulocytes and monocytes, useful for fighting infections. Gm-csf did not appear to be a good predictor of future healing ...

» Read our Company Profiles

2 Companies for Granulocyte

Citrix

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.